M. Bekkers

Influence of Plasma Triglyceride and Plasma Cholesterol Levels on the Clearance Rate of Fibrinogen

J. Emeis, M. P. Maat, M. Verschuur, 2001, Annals of the New York Academy of Sciences.

HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY Increased Clearance Explains Lower Plasma Levels of Tissue-Type Plasminogen Activator by Estradiol: Evidence for Potently Enhanced Mannose Receptor Expression in Mice

T. Kooistra, L. Havekes, M. Lansink, 2016 .

Polylysine as a Vehicle for Extracellular Matrix-Targeted Local Drug Delivery, Providing High Accumulation and Long-Term Retention Within the Vascular Wall

D. Rijken, D. V. Sakharov, J. Emeis, 2001, Arteriosclerosis, thrombosis, and vascular biology.

Negative effects of rofecoxib treatment on cardiac function after ischemia-reperfusion injury in APOE3Leiden mice are prevented by combined treatment with thromboxane prostanoid-receptor antagonist S18886 (terutroban).

J. Jukema, P. Steendijk, J. V. D. van der Hoorn, 2008, Critical care medicine.

Thrombolytic Treatment with Tissue-type Plasminogen Activator (t-PA) Containing Liposomes in Rabbits: a Comparison with Free t-PA

D. Crommelin, C. Kluft, J. Emeis, 1995, Thrombosis and Haemostasis.

Binding and retention of polycationic peptides and dendrimers in the vascular wall

D. Filippov, D. Rijken, D. V. Sakharov, 2003, FEBS letters.

HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY Increased Clearance Explains Lower Plasma Levels of Tissue-Type Plasminogen Activator by Estradiol: Evidence for Potently Enhanced Mannose Receptor Expression in Mice

T. Kooistra, L. Havekes, M. Lansink, 2016 .